Clinical Trials Browser

Phase 1 × Melanoma × Immunotherapy, Adoptive × Clear all

NCT00324623 2012-11-20

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

Phase 1 Completed

Melanoma